Aldeyra Therapeutics, Inc.
2020 Q2 - 2025 Q4 (23 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/12/2026 | 63 | 0.0% | 12,187 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 51 | 0.0% | 9,687 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 27 | 0.0% | 6,992 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 40 | 0.0% | 6,992 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 35 | 0.0% | 6,992 | 12/31/2024 |
| 2024 Q3 | 11/13/2024 | 34 | 0.0% | 6,400 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 21 | 0.0% | 6,400 | 6/30/2024 |
| 2024 Q1 | 5/15/2024 | 17 | 0.0% | 5,295 | 3/31/2024 |
| 2023 Q4 | 8/15/2024 | 19 | 0.0% | 5,295 | 12/31/2023 |
| 2023 Q3 | 8/15/2024 | 30 | 0.0% | 4,545 | 9/30/2023 |
| 2023 Q2 | 8/15/2024 | 93 | 0.0% | 11,030 | 6/30/2023 |
| 2023 Q1 | 8/15/2024 | 110 | 0.0% | 11,030 | 3/31/2023 |
| 2022 Q4 | 8/15/2024 | 69 | 0.0% | 9,930 | 12/31/2022 |
| 2022 Q3 | 8/15/2024 | 56 | 0.0% | 10,430 | 9/30/2022 |
| 2022 Q2 | 8/15/2024 | 33 | 0.0% | 8,280 | 6/30/2022 |
| 2022 Q1 | 8/15/2024 | 30 | 0.0% | 6,680 | 3/31/2022 |
| 2021 Q4 | 8/30/2024 | 45 | 0.0% | 11,180 | 12/31/2021 |
| 2021 Q3 | 8/30/2024 | 98 | 0.0% | 11,180 | 9/30/2021 |
| 2021 Q2 | 8/30/2024 | 122 | 0.0% | 10,760 | 6/30/2021 |
| 2021 Q1 | 8/30/2024 | 196 | 0.0% | 16,475 | 3/31/2021 |
| 2020 Q4 | 8/30/2024 | 104 | 0.0% | 15,125 | 12/31/2020 |
| 2020 Q3 | 8/30/2024 | 92 | 0.0% | 12,350 | 9/30/2020 |
| 2020 Q2 | 8/30/2024 | 24 | 0.0% | 5,850 | 6/30/2020 |